ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Month: September 2023
ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
Full commercial launch of NexoBrid marks important first step to becoming the new standard of…
Spectral AI to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
DALLAS, Sept. 20, 2023 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI”…
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
Full commercial launch of NexoBrid marks important first step to becoming the new standard of…
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
Spectral AI to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
DALLAS, Sept. 20, 2023 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI”…
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023…
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023…
Societal CDMO Announces Corporate Restructuring
Strategic Realignment Designed to Right Size Organization to Address Macro Pharma Market Financing Challenges and…
Societal CDMO Announces Corporate Restructuring
Strategic Realignment Designed to Right Size Organization to Address Macro Pharma Market Financing Challenges and…
Dyne Therapeutics Receives FDA Orphan Drug Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1
– On Track to Report Initial Data from the Global, Multiple Ascending Dose Phase 1/2…
PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
PRINCETON, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech…
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
IRVINE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today…
Spero Therapeutics to Present at Cantor’s Global Healthcare 2023 Investor Conference
CAMBRIDGE, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset…
Flowserve Appoints Cheryl H. Johnson to Board of Directors
DALLAS–(BUSINESS WIRE)–Flowserve Corporation (NYSE:FLS), a leading provider of flow control products and services for the…
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Late-breaking poster presentation to highlight updated Phase 1 clinical data of PC14586, a first-in-class precision…
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ARLINGTON, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — KALA BIO, Inc. (Nasdaq:KALA), today announced that…
Inventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea
Hepalys Pharma, Inc. is a new company created by Catalys Pacific and in which Inventiva…